-
(www.scilifelab.se ). NGI is one of the largest academic providers of next-generation sequencing technology (NGS) and SNP genotyping services in Europe, offering world-class technologies and support to researchers
-
strong merit. We are seeking a post-doc candidate who is passionate about answering biological questions related to cancer immunology using cutting edge technology in close collaboration with experimental
-
KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health Job description Professor Tuuli Lappalainen’s research group is looking for a researcher for
-
is advantageous as well as in CRISPR/Cas9 genetic engineering. Previous work with yeast or another unicellular organism, as well as high throughput screening is also advantageous. Additionally, you
-
changes, cancer cells can evade the strict control on growth and form a tumor. New studies emphasize the importance of communication between tumor cells and the surrounding tissue for cancer to develop
-
laboratories of the partnership adhere to the EMBL model for research organisation, mentorship and evaluation. Funded by the Swedish Research Council at Umeå University with its strong community of researchers
-
of Technology (MIT), and Chalmers Institute of Technology. Your mission You will design and analyze a high-throughput stimulus-response experiment in cancer and stroma cells that will be conducted at our core
-
, and industry partners across Europe and beyond. Host Universities: Collaborate with one of nine leading Swedish universities. What You get Transferable Skills: E.g. Open science, FAIR, communication